RenovoRx Inc
Change company Symbol lookup
Select an option...
RNXT RenovoRx Inc
ESTC Elastic NV
CMBM Cambium Networks Corp
S SentinelOne Inc
BAC Bank of America Corp
SDA SunCar Technology Group Inc
RAIN Rain Oncology Inc
EOI Eaton Vance Enhanced Equity Income Fund
OLNCF Omni Lite Industries Canada Inc
RGNX Regenxbio Inc
Go

Health Care : Biotechnology |
Company profile

RenovoRx, Inc. is a clinical-stage biopharmaceutical company. The Company is engaged in delivering its targeted intra-arterial (IA) delivery of chemotherapy directly to solid tumors. The Company’s therapy platform, RenovoRx Trans-Arterial Micro-Perfusion (RenovoTAMP) utilizes chemotherapeutics. RenovoTAMP combines its patented delivery system, RenovoCath, with small molecule chemotherapeutic agents, which can be forced across the vessel wall using pressure, targeting these anti-cancer drugs locally to the solid tumors. Its first product candidate, RenovoGem, is a drug /device combination consisting of intra-arterial gemcitabine and RenovoCath. RenovoGem has been developed for the treatment of two rare diseases: pancreatic cancer and cholangiocarcinoma (CCA). It has completed the first of two planned interim analyses of the ongoing open-label Phase III TIGeR-PaC clinical trial.

Price
Delayed
$2.01
Day's Change
-0.10 (-4.74%)
Bid
--
Ask
--
B/A Size
--
Day's High
2.20
Day's Low
2.01
Volume
(Heavy Day)

Today's volume of 16,126 shares is on pace to be much greater than RNXT's 10-day average volume of 23,170 shares.

16,126
  • Prev Close
    2.11
  • Today's Open
    2.15
  • Day's Range
    2.01-2.20
  • Avg Vol (10-day)
    23.2K
  • Last (time)
    11:01a ET 06/02/23
  • Last (size)
    1
  • 52-Wk Range
    1.50 - 5.75
    LowHigh
  • (12/06/22 - 03/07/23)
    34.00%
  • 106.6%
  • Market Cap
    20.4M
  • Shares Outstanding
    10.1M
  • -1.12
  • --
  • No dividend
  • Ex-dividend Date
    No dividend
  • Dividend Pay Date
    No dividend
  • --
  • 21.60
  • (% of float 05/15/23)
    0.16

Latest News

June 01, 2023
8:30 am ET
BusinessWire
May 25, 2023
8:30 am ET
BusinessWire
May 24, 2023
8:30 am ET
BusinessWire
May 15, 2023
8:30 am ET
BusinessWire
May 01, 2023
8:30 am ET
BusinessWire
April 28, 2023
8:30 am ET
BusinessWire
8:30 am ET
BusinessWire
April 27, 2023
8:30 am ET
BusinessWire
April 14, 2023
8:30 am ET
BusinessWire
April 11, 2023
8:30 am ET
BusinessWire
March 30, 2023
12:20 pm ET
BusinessWire
8:30 am ET
BusinessWire
March 08, 2023
8:30 am ET
BusinessWire
Go to all current & historical news

Earnings Calendar and Events Data provided by |Terms of Use| © 2023 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2023. All rights reserved.